Novo Nordisk - NovoSeven: clinical trials, ain't they a bitch!?

Novo Nordisk said it has halted its Phase 3 clinical trials of the NovoSeven drug (recombinant activated factor VII) to stop bleeding in patients with severe injuries, saying they would not have a positive outcome. The pharmaceutical company said: "The analysis predicted a low likelihood of obtaining a positive trial outcome with the planned study population, and as a consequence, Novo Nordisk has decided to discontinue the trial."